JEFFREY L EDWARDS
CIK 1190642 · EVP, Fin & Bus. Dev., CFO · last filed 2026-06-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$570.9K
Companies
7
Total Filings
60
Lifetime Open-Market Net
-$59.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYNB | Director | — | $6.97 | — | $0 | 1 | 2026-06-17 |
| BIO.B | Director | 715 | $309.37 | $221.2K | $0 | 3 | 2026-04-23 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 1,675 | $9.75 | $16.3K | -$135.6K | 11 | 2025-06-06 |
| LFCR | Director | 79,667 | $4.39 | $349.7K | $0 | 5 | 2024-07-10 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | — | $0.35 | — | $0 | 7 | 2024-06-21 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 12,457 | $8.76 | $109.1K | $0 | 5 | 2022-06-07 |
| ALLERGAN INC (AGN) Delisted | EVP, Fin & Bus. Dev., CFO | 58,153 | — | — | -$59.07M | 27 | 2014-02-25 |
Recent Filings · Page 2 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-09 | KYNB | Notice (144) | −7,889 | -$135.6K | EDGAR |
| 2023-06-09 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | +400 | -$135.6K | EDGAR |
| 2023-06-05 | LFCR | Grant (A) | +18,182 | $0 | EDGAR |
| 2023-06-01 | LFCR | Exer (M) | +9,474 | $0 | EDGAR |
| 2023-02-02 | LFCR | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +15,777 | $0 | EDGAR |
| 2022-06-07 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +7,059 | $67.1K | EDGAR |
| 2022-06-02 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-18 | LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Mixed | +5,398 | $52.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.